NFE2L2 and frontotemporal dementia: In C9orf72-linked ALS/FTD, Nrf2 activation alleviates key molecular pathologies by reducing DPR accumulation and RNA foci, restoring nuclear TDP-43, and enhancing RNA quality control pathways such as NMD and R-loop resolution.